(Q37596851)

English

Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target

scientific article published on 03 October 2013

In more languages
default for all languages
No label defined

No description defined

Statements

Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit